Oppenheimer & Co’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-171
| Closed | -$1.39K | – | 1500 |
|
|
2023
Q1 | $1.39K | Hold |
171
| – | – | ﹤0.01% | 1378 |
|
|
2022
Q4 | $2.03K | Hold |
171
| – | – | ﹤0.01% | 1348 |
|
|
2022
Q3 | $2K | Hold |
171
| – | – | ﹤0.01% | 1359 |
|
|
2022
Q2 | $6K | Hold |
171
| – | – | ﹤0.01% | 1402 |
|
|
2022
Q1 | $7K | Hold |
171
| – | – | ﹤0.01% | 1462 |
|
|
2021
Q4 | $7K | Hold |
171
| – | – | ﹤0.01% | 1484 |
|
|
2021
Q3 | $12K | Hold |
171
| – | – | ﹤0.01% | 1484 |
|
|
2021
Q2 | $13K | Hold |
171
| – | – | ﹤0.01% | 1499 |
|
|
2021
Q1 | $11K | Hold |
171
| – | – | ﹤0.01% | 1432 |
|
|
2020
Q4 | $6K | Hold |
171
| – | – | ﹤0.01% | 1338 |
|
|
2020
Q3 | $9K | Sell |
171
-58
| -25% | -$3.05K | ﹤0.01% | 1272 |
|
|
2020
Q2 | $9K | Hold |
229
| – | – | ﹤0.01% | 1247 |
|
|
2020
Q1 | $6K | Hold |
229
| – | – | ﹤0.01% | 1187 |
|
|
2019
Q4 | $11K | Hold |
229
| – | – | ﹤0.01% | 1270 |
|
|
2019
Q3 | $11K | Hold |
229
| – | – | ﹤0.01% | 1249 |
|
|
2019
Q2 | $21K | Sell |
229
-14
| -6% | -$1.28K | ﹤0.01% | 1292 |
|
|
2019
Q1 | $36K | Hold |
243
| – | – | ﹤0.01% | 1330 |
|
|
2018
Q4 | $38K | Buy |
+243
| New | +$38K | ﹤0.01% | 1218 |
|